Immune Response News and Research

RSS

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Staphylococcal and streptococcal infections affect millions of individuals each year. They are a leading cause of sepsis and account for many cases of pneumonia and post-surgical infections.

8 Oct 2016

Researchers explain why explain why some tumors recur after immunotherapy

Immunotherapy is a new and highly promising form of treatment for cancer. In many patients, however, tumors recur after immunotherapy.

7 Oct 2016

Study provides new insights into Zika's rapid infection and risk for transmission

Though first documented 70 years ago, the Zika virus was poorly understood when it burst onto the scene in the Americas in 2015.

7 Oct 2016

Research gains new insights into how virus that causes cervical cancer evades immune system

Researchers from New Zealand's University of Otago have gained fresh insights into how one of the main viruses that cause cervical cancer evades its hosts' immune systems.

6 Oct 2016

Beckman Coulter award enables two scientists to attend Advanced Analytical Ultracentrifugation Workshop and Symposium

Beckman Coulter Life Sciences continues its collaboration with one of the nation’s leading Industry/University Cooperative Research Centers.

From Beckman Coulter Life Sciences - Centrifugation 6 Oct 2016

Treatment using PARP inhibitor shrinks tumors in breast cancer patients with BRCA mutations

All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.

5 Oct 2016

Gut may play key role in preventing Parkinson's disease

Your gut may play a pivotal role in preventing the onset of Parkinson's disease. And the reason may be its knack for sleuthing.

5 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

Study suggests targeting UNG enzyme may help treat non-Hodgkin's lymphoma

Researchers have discovered that an enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes to facilitate the proliferation of these antibody-producing cells in response to infection.

3 Oct 2016

Researchers uncover pneumonia causing bacteria as trigger for autoimmune disease GBS

Guillain-Barré syndrome (GBS) is an acute life-threatening disease of the nervous system that leads to sensory disturbances and acute flaccid paralysis.

3 Oct 2016

Inhibiting single protein could help restore sensitivity to common treatment for breast cancer

A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.

3 Oct 2016

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.

3 Oct 2016

New portable adhesive patch drives small electrical current to promote wound healing

Good news for the millions of people who suffer from skin wounds that won't heal. A team of researchers at The Ohio State University has brought a potentially transformative solution to the problem by creating a portable adhesive patch that drives a continuous, small electrical current to stimulate healing and reduce the risk of infection.

30 Sep 2016

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.

27 Sep 2016

Salk scientist Clodagh O'Shea named recipient of grant from Faculty Scholars Program

Clodagh O'Shea, an associate professor in the Salk Institute's Molecular and Cell Biology Laboratory, is among the first recipients of a grant from the Faculty Scholars Program, a new partnership of Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation and the Simons Foundation for early career researchers whose work shows the potential for groundbreaking contributions in their fields.

24 Sep 2016

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.

21 Sep 2016

Three-dimensional heart patches may soon move closer to clinical application

The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.

21 Sep 2016

TSRI scientists shed light on molecular workings of MS drug

A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious.

21 Sep 2016

Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

An international team of researchers led by infectious disease experts at the University of Georgia has received $5.2 million from the National Institutes of Health to develop a more accurate, affordable diagnostic test for Chagas disease, a parasitic infection that kills more than 50,000 people each year in Central and South America.

21 Sep 2016

Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy.

19 Sep 2016

Immune Response News and Research

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Researchers explain why explain why some tumors recur after immunotherapy

Study provides new insights into Zika's rapid infection and risk for transmission

Research gains new insights into how virus that causes cervical cancer evades immune system

Beckman Coulter award enables two scientists to attend Advanced Analytical Ultracentrifugation Workshop and Symposium

Treatment using PARP inhibitor shrinks tumors in breast cancer patients with BRCA mutations

Gut may play key role in preventing Parkinson's disease

Antibody protection may help control infection caused by TB bacteria

Study suggests targeting UNG enzyme may help treat non-Hodgkin's lymphoma

Researchers uncover pneumonia causing bacteria as trigger for autoimmune disease GBS

Inhibiting single protein could help restore sensitivity to common treatment for breast cancer

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

New portable adhesive patch drives small electrical current to promote wound healing

Combination of different drugs could improve effect of immunotherapy on skin cancer

Salk scientist Clodagh O'Shea named recipient of grant from Faculty Scholars Program

Experimental drug may prevent development of multiple sclerosis in mice

Three-dimensional heart patches may soon move closer to clinical application

TSRI scientists shed light on molecular workings of MS drug

Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Understanding the DNA Damage Response in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News